Literature DB >> 1389761

Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina.

H el-Tamimi1, G J Davies.   

Abstract

OBJECTIVE: To study the effects on myocardial ischaemia of 50 mg of atenolol, 20 mg of slow release nifedipine, and their fixed combination given 12 hourly.
DESIGN: A treadmill exercise test and 24 hour ambulatory electrocardiographic monitoring were carried out after a period of five days off treatment (control) and at the end of three weeks of each treatment period. PATIENTS: 23 patients with stable angina pectoris, documented coronary artery disease, and a positive exercise test were randomised in a double blind, three way, cross over study.
RESULTS: Compared with the control, nifedipine significantly induced an increase in resting heart rate of (mean (SEM)) 14 (2) beats/min whereas atenolol and the combination significantly reduced it by 24 (2) and 20 (1) beats/min respectively. The number of exercise tests rendered negative after each intervention was five for nifedipine, nine for atenolol, and 11 for the combination. Compared with the control the time to the start of myocardial ischaemia (1 mm ST segment depression) during exercise significantly increased by 3.2 (0.6) min after nifedipine, by 4.6 (0.4) min after atenolol, and by 4.6 (0.5) min after the combination; rate-pressure product (beats/min. mm Hg) at 1 mm ST segment depression increased by 2824 (970) after nifedipine but fell by 4436 (900) and 4501 (719) after atenolol and the combination. The weekly frequency of angina was reduced from a mean of five while taking nifedipine, to three while taking atenolol, and to two while taking the combination. The total ischaemic time during ambulatory monitoring was significantly reduced from 69 (17) min during control to 37.5 (9.8) min during nifedipine, to 15.6 (5.5) min during atenolol, and to 6.5 (2.7) min during the combination.
CONCLUSION: The undesirable effect of a high basal heart rate induced by nifedipine was neutralised by its combination with atenolol. Whereas atenolol and the combination were equally efficacious in controlling exercise induced ischaemia, the combination was more effective in reducing total ischaemic burden.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389761      PMCID: PMC1025073          DOI: 10.1136/hrt.68.9.291

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Medical therapy of chronic stable angina pectoris.

Authors:  A Maseri
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

2.  Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.

Authors:  J E Gage; O M Hess; T Murakami; M Ritter; J Grimm; H P Krayenbuehl
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

3.  Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.

Authors:  I N Findlay; K MacLeod; M Ford; G Gillen; A T Elliott; H J Dargie
Journal:  Br Heart J       Date:  1986-03

4.  The changing face of angina pectoris: practical implications.

Authors:  A Maseri
Journal:  Lancet       Date:  1983-04-02       Impact factor: 79.321

5.  Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog.

Authors:  R J Bache; B A Tockman
Journal:  Circ Res       Date:  1982-05       Impact factor: 17.367

6.  Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption.

Authors:  P Schanzenbächer; G Liebau; P Deeg; K Kochsiek
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

7.  Effects of preload on the transmural distribution of perfusion and pressure-flow relationships in the canine coronary vascular bed.

Authors:  A K Ellis; F J Klocke
Journal:  Circ Res       Date:  1980-01       Impact factor: 17.367

8.  Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Introduction.

Authors:  B Lown
Journal:  Am J Cardiol       Date:  1979-10-22       Impact factor: 2.778

9.  Nifedipine and propranolol: a beneficial drug interaction.

Authors:  H J Dargie; P G Lynch; D M Krikler; L Harris; S Krikler
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

Review 10.  Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris.

Authors:  S E Epstein; T L Talbot
Journal:  Am J Cardiol       Date:  1981-10       Impact factor: 2.778

View more
  2 in total

1.  Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.

Authors:  T E Meyer; C Adnams; P Commerford
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

Review 2.  North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. North of England Stable Angina Guideline Development Group.

Authors: 
Journal:  BMJ       Date:  1996-03-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.